R+D+I: Klinische Onderzoeken aan het Instituto Bernabeu
Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) NCT03701490
What is studied: It is the first clinical trial in the world to use Progesterone administered subcutaneously at a dose of 50 mg daily and compares it with standard vaginal administration.
Aim: We want to know the optimal treatment protocol that can improve the results through the administration route of the medication of patients who receive frozen embryos.
Start: March 2020
Location: Instituto Bernabeu Alicante
More information: For more information click here
For study details you can find them through the link